Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

St James's Hospital, Dublin

Edegem - UNIV UZ Antwerpen, Edegem

UZ Leuven, Leuven

Centre Hospitalier Universitaire de Liège, Liège

AZ Maria Middelares, Ghent

Northwell Health, Manhasset

Virginia Commonwealth University, Richmond

The University of North Carolina at Chapel Hill, Chapel Hill

Duke University Medical Center, Durham

Diabetes and Endocrinology Consultants, PC, Morehead City

Hospital Virgen de la Victoria, Málaga

Genoma Research Group, Inc, Miami

Florida Research Institute, Lakewood Rch

Hospital Universitario Marqués de Valdecilla, Santander

Hospital Virgen del Rocío, Seville

Hospital General Universitario de Valencia, Valencia

Universitätsklinikum Köln (AöR), Cologne

Universitätsklinikum Aachen, AöR, Aachen

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz

HOP Claude Huriez, Lille

Universitätsklinikum Frankfurt, Frankfurt am Main

Dallas Diabetes and Endocrine Center, Dallas

HOP La Pitié Salpêtrière, Paris

American Research Corporation at the Texas Liver Institute, San Antonio

Pinnacle Clinical Research, Live Oak

National Research Institute, Los Angeles

National Research Institute, Los Angeles

eStudySite, La Mesa

University of California San Diego, La Jolla

Southern California Research Center, Coronado

Quest Clinical Research, San Francisco

Universitätsklinikum Würzburg, Würzburg

Rutgers Robert Wood Johnson Medical School, New Brunswick

University of Calgary, Calgary

Toronto Liver Centre, Toronto

Universitätsklinikum Leipzig, Leipzig

Amsterdam UMC, Locatie AMC, Amsterdam

Maastricht Universitair Medisch Centrum, Maastricht

Radboud Universitair Medisch Centrum, Nijmegen

Hospital Vall d'Hebron, Barcelona

Queen Elizabeth Hospital, Birmingham

Aintree University Hospital, Liverpool

Manchester Royal Infirmary, Manchester

Royal Stoke University Hospital, Stoke-on-Trent